Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets.

Jiang, Zongzhi; Wang, Ziyi; Wei, Xiaojing; Yu, Xue-Fan

Jiang, Zongzhi; Wang, Ziyi; Wei, Xiaojing; Yu, Xue-Fan.

Afiliación

Jiang Z; Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
Wang Z; Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
Wei X; Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
Yu XF; Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.

Front Immunol ; 13: 1059994, 2022.

Article en En | MEDLINE | ID: mdl-36618399

Asunto(s)

Esclerosis Amiotrófica Lateral; Enfermedades Neurodegenerativas; Animales; Esclerosis Amiotrófica Lateral/diagnóstico; Esclerosis Amiotrófica Lateral/tratamiento farmacológico; Esclerosis Amiotrófica Lateral/etiología; Biomarcadores; Neuronas Motoras/metabolismo; Proteínas/uso terapéutico

Palabras clave

amyotrophic lateral sclerosis; animal model; biomarker; immunotherapy; inflammation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Esclerosis Amiotrófica Lateral Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google